About Cory Berkland
Cory Berkland is a chairman at Bond Biosciences.
Cory Berkland first appears on SEC filings in 2020.
Experience
This experience comes from Cory Berkland's profile and from SEC filings. For roles taken from filings, the years are when the filings name Cory Berkland in the role, so the role may have started earlier or lasted longer.
WL
Washington University in St. Louis Current
Professor
2023 – Present
KI
Kinimmune, Inc. Current
Co-founder and Chief Executive Officer
2020 – Present
Bond Biosciences, Inc. Current
Chairman
Co-founder and Chief Scientific Officer (2016 – Present)
2016 – Present · Parkville, MO
Develops oral drugs for people with diseases caused by excess ions.
TK
The University of Kansas
Solon E. Summerfield Distinguished Professor
2004 – 2023
OB
Orion BioScience
Co-founder and Chairman of the Board
2012 – 2020
OI
Orbis Biosciences, Inc.
Co-founder and Chief Scientific Officer
2007 – 2020
SV
Sofinnova Ventures
Entrepreneur In Residence
2014
SP
Savara Pharmaceuticals
Co-founder
2007 – 2014
Key Colleagues at Startups
The people Cory Berkland works with at each company, as listed on that company's latest Form D.
Bond Biosciences, Inc. · Form D/A, Oct 5, 2026
MB
Michael Beckloff
Director
TO
Timothy Opler
Director
Michael Riley
Executive officer and director
JS
Jay Shepard
Director